This study aims at investigating the epigenetic landscape of cardiomyocytes exposed to elevated glucose levels. High glucose (30 mM) for 72 hours determined some epigenetic changes in mouse HL-1 and rat differentiated H9C2 cardiomyocytes including upregulation of class I and III histone deacetylase protein levels and activity, inhibition of histone acetylase p300 activity, increase in histone H3 lysine 27 trimethylation, and reduction in H3 lysine 9 acetylation. Gene expression analysis focused on cardiotoxicity revealed that high glucose induced markers associated with tissue damage, fibrosis, and cardiac remodeling such as Nexilin (NEXN), versican, cyclic adenosine 5 0 -monophosphate-responsive element modulator (CREM), and adrenoceptor a2A (ADRA2). Notably, the transcription factor CREM was found to be important in the regulation of cardiotoxicityassociated genes as assessed by specific small interfering RNA and chromatin immunoprecipitation experiments. In CD1 mice, made hyperglycemic by streptozotoicin (STZ) injection, cardiac structural alterations were evident at 6 months after STZ treatment and were associated with a significant increase of H3 lysine 27 trimethylation and reduction of H3 lysine 9 acetylation. Consistently, NEXN, CREM, and ADRA2 expression was significantly induced at the RNA and protein levels. Confocal microscopy analysis of NEXN localization showed this protein irregularly distributed along the sarcomeres in the heart of hyperglycemic mice. This evidence suggested a structural alteration of cardiac Z-disk with potential consequences on contractility. In conclusion, high glucose may alter the epigenetic landscape of cardiac cells. Sildenafil, restoring guanosine 3 0 , 5 0 -cyclic monophosphate levels, counteracted the increase of CREM and NEXN, providing a protective effect in the presence of hyperglycemia. (Endocrinology 158: 2391(Endocrinology 158: -2405(Endocrinology 158: , 2017 P atients with type 1 or 2 diabetes may develop severe cardiomyopathy, leading to cardiac ischemia and failure (1). Diabetic cardiomyopathy is a multifactorial disorder, and different pathophysiological conditions have been found to have an impact on its progression, including oxidative stress, inflammation, hyperglycemia,
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In several animal models of hyperglycemia, insulin resistance, metabolic syndrome, or diabetes, the upregulation of NO has been associated with significant cardioprotection, and different mechanisms have been reported underlying this effect, including a positive outcome on mitochondrial function and the respiratory chain (7) . An important aspect of NO bioactivity resides in its capacity to reduce oxidative stress while performing protein S-nitrosylation on cysteine having an impact on the stability and function of metabolically and epigenetically active enzymes (8) . Of note, this property of NO has important consequences on the epigenetic regulation of lysine-modifying enzymes, including histone deacetylases (HDACs) (9, 10) .
Since the discovery that the effect of nitroglycerine could be mediated by NO (11) , a large number of drugs entered clinical use for the treatment of angina, hypertension, and ischemic cardiomyopathy (12) . More recently, the inhibitors of phosphodiesterase 5, including sildenafil, which upregulate guanosine 3 0 ,5 0 -cyclic monophosphate (cGMP) levels, have been found beneficial not only for the treatment of erectile dysfunction but also for pulmonary hypertension and diabetic cardiomyopathy (13, 14) . In particular, in an experimental in vivo model of hyperglycemia induced by streptozotocin (STZ), sildenafil has been reported to counteract the proinflammatory and cardiomyopathic effects of hyperglycemia (15) . In this context, hyperglycemic signaling effectors that lead to altered gene expression and cardiomyopathy are not completely characterized; however, a body of literature suggests that epigenetic changes play an important role (16) , and a number of transcription factors have been implicated in the onset of the aberrant hyperglycemic response (17) (18) (19) (20) . Interestingly, the cyclic adenosine 5 0 -monophosphate (cAMP)-responsive element modulator (CREM) factor (21) and related family members recently emerged as involved in gene expression regulation under pathophysiological conditions associated with different forms of cardiomyopathy (22) (23) (24) (25) . In humans and mice, CREM is present with a multitude of isoforms (.20), of which full-length CREM, the object of investigation in this study, is one of the most represented and functionally active (26) (27) (28) . CREM is structurally similar to the cAMP response element binding protein and it seems to play an important role in the regulation of spermatogenesis (29) , in T lymphocyte function (30) , and in specific endocrine organs, including adrenal and pituitary glands (31) . In the heart, a limited number of studies indicate that CREM, or members of the cAMP response element binding protein /CREM family, are important in cardiac morphogenesis (23, 32) . However, more recent evidence pointed out that CREM might play a role in pathophysiological conditions associated with cardiomyopathy and heart failure (24) . Whether CREM directly regulates genes involved in cardiac degeneration is currently unclear. The role of CREM translating the physiopathological consequences of hyperglycemia and/or other prediabetic conditions it is also undetermined. In this direction, prior studies indicated that members of the CREM family could be involved in the regulation of gene expression in pancreatic islands exposed to high glucose (HG) or high fatty acid regimens (33) .
In this study, we explored the epigenetic effect of HG on cardiomyocytes and that of prolonged hyperglycemia on mouse heart. Data present the functional role of transcription factor CREM in gene expression regulation in response to HG and NO signaling activation.
Materials and Methods

Animal care and treatment
All experiments were conducted according to protocols reviewed and approved by the Italian National Institutes of Health (DGSAF0005330 no. 202/2016-PR) and the Institutional Animal Care of Università Cattolica (Rome, Italy, 100/2003-A). Animals were housed and handled in accordance with European Community guidelines (Council Directive 2010/ 63/EU). All commercial products were used according to manufacturers' instructions, and much effort was made to limit the number of animals used and to minimize their suffering. Diabetes was induced in male CD1 mice (Charles River Laboratories, Research Models and Services, Calco, Italy) by injection of STZ (40 mg/kg body weight intraperitoneally per day for 5 days; Sigma-Aldrich, St. Louis, MO) as described in Moore et al. (34) . Hyperglycemia was confirmed measuring glucose levels in blood (Supplemental Fig. 4A ). Three months after STZ injection, sildenafil (Sigma-Aldrich) was given daily by intraperitoneal injection at a concentration of 3 mg/kg for 12 weeks as previously described (35, 36) . Age-matched normal animals were injected with vehicle only and used as nondiabetic control for those that received STZ and/or sildenafil.
Cell culture and treatment
Cardiomyocyte cell line HL-1 [research resource identifier (RRID): CVL_0303], established from an AT-1 subcutaneous tumor excised from an adult female C57BL/6J mouse, was cultured in Claycomb medium as previously described (37) . Embryonic cardiac H9C2 cells (RRID:CVCL_0286), derived from the ventricular part of an E13 BDIX female rat heart (SigmaAldrich), were cultured and differentiated as previously described (38, 39) . Briefly, H9C2 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) medium supplemented with 1% fetal bovine serum to induce skeletal muscle differentiation, whereas to induce cardiac differentiation, cells were cultured in DMEM supplemented with 1% donor calf serum (DCS). The culture medium was replaced every 2 days. After 7 days of differentiation, glucose (D-glucose, Sigma-Aldrich) at different concentration (5.0 mM referred to as low glucose and 30 mM as HG) was added to the culture medium for 72 to 96 hours; mannitol (30 mM, Sigma-Aldrich) or L-glucose (30 mM, Sigma-Aldrich) was used as controls. When appropriate, each of the following compounds was administered 30 minutes prior to HG exposure: diethylenetriamine (DETA)/NO (100 mM, Sigma-Aldrich), sildenafil (1 nM, SigmaAldrich); ODQ (10 mM, Sigma-Aldrich), and 8-Br-cGMP (10 mM, Sigma-Aldrich) as in Podda et al. (40) .
Scratch test
A scratch assay was performed as described previously with few modifications (41) . Briefly, cells were cultured to confluence. The monolayer was scraped with a p200 pipette tip in a straight line to create a scratch. Images were obtained by using a phase-contrast microscope (Axio microscope with Axio Cam ERc5s from Carl Zeiss Microscopy (Thornwood, NY); objective 310) at time 0 and after 24 hours, and the distance between edges was measured by phase-contrast microscopy and analyzed by ZEN imaging software (Zeiss). Data were represented as a percentage of the original gap.
Histone acetyltransferase and HDAC activities
Measurement of histone acetyltransferase (HAT) and HDAC activities were analyzed as previously described (42, 43) . Briefly, p300-associated and HDAC2-associated activities were evaluated after immunoprecipitation using 400 mg of protein extract. Normal IgG served as negative control. Forty micrograms of protein extract was used to evaluate total HAT (BioVision Inc., Milpitas, CA) and HDAC (Upstate Biotechnology, Lake Placid, NY) activities following the manufacturers' instructions. For antibodies used, see Table 1 .
Immunocytochemistry and immunohistochemistry
Cells were grown on coverslips and treated as described above. Before assays, cells were rinsed with phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde, and permeabilized with Triton X-100 (0.2%). Hearts were isolated, fixed in formalin, and embedded in paraffin as described (44, 45) . Sections were used to perform hematoxylin and eosin staining, Azan-Mallory staining, and immunofluorescence. Samples were then blocked with 10% bovine serum albumin in PBS and incubated overnight (at 4°C) with the primary antibodies. The following day, samples were washed three times with PBS and incubated for 1 hour at room temperature with secondary antibodies: anti-rabbit fluorescein isothiocyanate and anti-mouse tetramethylrhodamine isothiocyanate (Lab Vision Corporation, Fremont, CA) were used when appropriate. Before analysis, nuclei were marked with 4 0 ,6-diamidino-2-phenylindole or TO-PRO-3 and samples coverslipped with Fluoromount aqueous mounting medium (Sigma-Aldrich).
Imaging
Two-dimensional images were created as the maximum intensity projection of Z-stack realized with a confocal laser scanning system (TCS-SP2, Leica Microsystems, Wetzlar, Germany) equipped with an Ar/ArKr laser for 488-nm excitation and HeNe laser for 543-nm excitation (46) . Counts of immunoreactive cells were performed in at least five random 340 magnification fields for each experiment, and data were expressed as percentages of positive cells within the same fields [mean 6 standard error of the mean (SEM) of three independent experiments]. Immunocytochemistry was obtained with epifluorescence microscopy (Zeiss Axiovert 25 microscope) fitted with a 363 immersion objective and a standard filter set as described in Zanni et al. (47) . Morphological analysis of H9C2 cell was performed by using an Olympus BX51 microscope (Olympus, Tokyo, Japan).
Western blot assay
Protein extracts were obtained as in Nanni et al. (48) . Total proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using a 4% to 12% gradient Invitrogen precast gel [NuPAGE and 2-(N-morpholino)ethanesulfonic acid buffer]. Specific protein signals were revealed with ECL Prime (Amersham, GE Healthcare, Amersham Place, UK) and detected by UVIdoc (Eppendorf, Hamburg, Germany). The intensity of each band was evaluated by using UVIdoc and/or the ImageJ 1.8 software (National Institutes of Health, Bethesda, MD).
RNA interference
Proliferating H9C2 cells were plated at a density of 0.8 to 3.0 3 10 5 cells/mL in DMEM low glucose supplemented with 10% fetal bovine serum. The cells were then transfected by using a TransIT-X2 dynamic delivery system (Integrated DNA Technologies, Coralville, IA) and 25 nM small interfering RNA (siRNA; TriFECTa and DsiDNA duplex, Integrated DNA Technologies) following the manufacturer's instruction. After 24 hours, culture medium was replaced with fresh medium containing 1% DCS. After 3 days cells were exposed to HG (30 mM) or kept in low glucose for 72 hours before harvesting.
RNA extraction and quantitative real-time polymerase chain reaction analysis RNA isolation, complementary DNA preparation, and RNA quantification were performed as described (48, 49) . Briefly, quantitative real-time polymerase chain reaction (qRT-PCR) was repeated three times in duplicate on an ABI Prism 7500 and/or QuantStudio 5 detection system (Applied Biosystems, Foster City, CA) and quantified with standard curve methods (5 log dilution); b-actin or aldolase served as endogenous controls. Expression of the rat calcium voltage-gated channel subunit a1C (Cav1.2) was detected by Prime Time assay and a FAM-labeled probe (Integrated DNA Techonlogies) with TaqMan master mix (Applied Biosystems). Primers, used with SYBR Green master mix (Applied Biosystems), were as in Nanni et al. Gene expression profiling by quantitative polymerase chain reaction array
Gene expression analysis was assessed by a predefined quantitative polymerase chain reaction (qPCR) array profiling 84 key genes involved in cardiotoxicity according to the manufacturer's instructions (SABiosciences, Qiagen, Valencia, CA). Statistical analysis and plots were performed using Webbased online RT 2 Profiler PCR array data analysis version 3.5 as previously described (43, 50) .
Chromatin immunoprecipitation
Chromatin cross-linking and chromatin immunoprecipitation (ChIP) assays were performed as described (44, 45, 48, 49) , using antibodies specific to CREM, HDAC1, histone H3 lysine 9 acetylation (H3K9Ac), and pan-acetylated H3 (panH3Ac). Negative controls were generated omitting antibody. DNA fragments were recovered and analyzed by qPCR as previously described (48, 49) . Briefly, qPCR was performed in duplicate or triplicate, and the data, normalized to the corresponding DNA input control, were represented as relative enrichment. Promoter analysis was performed by using Matinspector (Genomatix Software) and TRANSFAC 7.0 software to identify cAMP responsive elements (CRE) and CREM-tauspecific binding site, respectively. Primers were as follows: rat NEXN promoter, 
Statistical analysis
Data are expressed as mean 6 SEM or as fold of induction as indicated in the figure legends. Statistical analyses were performed by using SigmaPlot 13. Significance was calculated using a two-tailed t test or one-way analysis of variance. Differences between groups were calculated with analysis of variance and a post hoc Tukey honestly significant difference test with a Bonferroni correction. A P value of ,0.05 was considered significant.
Results
In vitro-differentiated cardiomyocytes adapt their epigenetic landscape in response to HG To investigate the effect of low and high concentrations of glucose on cardiomyocytes, we took advantage from the properties of the H9C2 cell line (38, 39). These cells have been isolated from the left ventricle of a Fig. 1B ) (51) . Additionally, other structural and functional markers such as desmin (52) and the heavy myosin chain (MF20) were found expressed in these cells by western blotting analysis (Supplemental Fig. 1C) . In differentiated H9C2 cardiomyocytes the expression of Cav1.2, important for cardiomyocyte contractility (53), has been further confirmed by confocal analysis (Supplemental Fig. 1D ). To verify the effect of glucose on cellular function, we tested whether HG exposure (30 mM for 72 hours) could affect the migration ability of cardiomyocyte-derived H9C2 or that of the atrial cardiac cell line HL-1 (expression of cardiac proteins in HL-1 cardiomyocytes is shown in Supplemental Fig. 2A ). We found that HG inhibited migration of both types of cardiac cells (Supplemental Fig. 1E and 1F ). In light of this evidence, we explored the effect of HG on the epigenetic landscape of our cells. Fig. 1(a) shows that HG increases the expression of important HDACs, including HDAC1, HDAC2, and SIRT1 in HL-1 cells. In agreement with the unbalanced expression of epigenetic enzymes driven by HG treatment, we found that the global density of histone H3 lysine 27 trimethylation (H3K27me3) increased whereas the signal generated by a panH3Ac antibody became negligible. In this condition the expression of the lysine acetylase PCAF was induced although total H3 acetylation decreased. Similar results were obtained with differentiated H9C2 cardiomyocytes cultured in HG. Fig. 1(b) shows that class I HDAC1, 2, and 3, but not class II HDAC 4 and 5, were increased above control levels similarly to SIRT1. Consistently, histone acetylases p300 and PCAF remained elevated in the presence of HG; however, total histone H3 acetylation dramatically decreased as indicated by the pan-acetylated H3 signal. As in HL-1, H3K27me3 was significantly upregulated in HG condition. Consistently, the total acetylation activity present in H9C2 cells and that associated with the histone acetylase p300 were significantly decreased [ Fig. 1(c) ]. Conversely, HDAC function increased, especially the one associated with HDAC2 [ Fig. 1(d) ].
NO normalizes epigenetic and gene expression changes induced by HG NO is a potent regulator of the epigenome landscape (54) , and important epigenetic effects of NO are consequence of the NO-dependent production of cGMP (55) . Notably, NO production or the cGMP-dependent signaling pathway can be both inhibited by HG (4). To explore whether the epigenetic landscape of H9C2 cells could be rescued by NO, experiments in which cells were treated with the NO donor DETA/NO or the PDE5 inhibitor sildenafil, which elevates the intracellular levels of cGMP, were performed. Fig. 2(a) shows western blotting analysis of HDAC1, HDAC3, SIRT1, PCAF, and H2K27me3 in the presence of DETA/NO or sildenafil. The results indicate that increasing the intracellular level of NO or cGMP is sufficient to normalize HDACs and PCAF expression as well as the global H3K27me3 signal. This finding prompted us to investigate the effect of HG and that of the NO pathway on the expression of target genes. Supplemental Fig. 2 shows the effect of HG and DETA/NO on the expression of genes associated with cardiotoxicity. Specifically, it shows that a number of transcripts were significantly upregulated in HL-1 cells exposed to HG (n = 18, P , 0.05), including transcription factor CREM, VCAN, ADRA2, and NEXN, all known to be associated with cardiomyopathy (24, 56, 57) . This result was validated by direct qRT-PCR in HL-1 [ Fig. 2(b) ] and in differentiated H9C2 [ Fig. 2(c) ] in which the level of transcripts from CREM, NEXN, and ADRA2 were measured. The result shown in Fig. 2(d) confirmed that HG increased expression of these genes although they were significantly downregulated in the presence of DETA/NO or sildenafil. These transcripts synthesize important structural and functional proteins in the heart. The presence of increased NEXN and VCAN proteins was further analyzed by confocal microscopy (Supplemental Fig. 2D ). To provide further information about the relevance of the NO/cGMP pathway in response to HG, a series of experiments were performed in differentiated H9C2 cells treated with guanylate cyclase inhibitor (ODQ), CamKII inhibitor, DETA/NO, or 8-brcGMP. All the conditions were tested in the presence of low glucose or HG. Fig. 2(e) shows that whereas CamKII inhibitor marginally affected protein expression, in the presence of ODQ, which reduces cGMP synthesis, all proteins were significantly increased in spite of low glucose, indicating that production of cGMP is important for the biological effect of NO. Consistently, treatment with DETA/NO or 8-Br-cGMP reduced the level of all proteins in the presence of HG, thus suggesting that perturbation in the NO/cGMP pathways is a crucial component of the pathophysiological context created by HG.
CREM binds to NEXN and ADRA2 promoters and regulates their expression
Transcription factor CREM has been reported to be involved in cardiomyopathy (24) . We found that HG induces its expression at messenger RNA (mRNA) and protein levels ( Fig. 2; Supplemental Fig. 2) . The properties of CREM as a transcription factor are poorly understood; furthermore, its targets have not been thoroughly investigated yet. Interestingly, genes such as NEXN or ADRA2, which are both upregulated by HG, are enriched by cAMP responsive element binding sites in their promoter region. To investigate the possibility that CREM could directly binds these regions, a series of ChIP experiments were performed. Fig. 3(a) shows the presence of CREM on NEXN and ADRA2 promoters [ Fig. 3(a) ]. The recruitment of CREM increased in cells treated with HG, and the signal from the H3K9Ac antibody accumulated in the same condition was paralleled by a reduction of HDAC1 occupancy [ Fig. 3(a) ]. Functional experiments aimed at CREM knockdown by siRNA showed a dramatic reduction of NEXN and ADRA2 protein expression, but not SIRT1, despite the presence of HG [ Fig. 3(b) ]. Taken together, these results suggest that CREM could be activated by HG and that it may be involved in the regulation of genes important for cardiac function or cardiomyopathy.
Prolonged hyperglycemia induces structural cardiac alterations, changes in the epigenetic landscape, and alters gene expression in mice
To investigate in vivo the effect of prolonged hyperglycemia on the epigenetic changes and expression of the genes described above, CD1 mice were injected with STZ and evaluated during a time course of 1, 3, and 6 months. Fig. 4(a) shows the levels of lysine 27 trimethylated and lysine 9 acetylated of H3 evaluated by confocal analysis. Specifically, H3K27me3 increased significantly in the heart of CD1 mice at 3 months after STZ injection, whereas H3K9Ac decreased proportionally. In light of this evidence, we reasoned that gene expression could be changed in hyperglycemic mice. Fig. 4(b) shows a progressive accumulation of ANP and BNP (58, 59) , both of which were significantly elevated at the 6 month time point after STZ injection. This alteration was associated with accumulation of NEXN, ADRA2, and CREM mRNA and NEXN and CREM proteins as shown in Fig. 4(c) and 4(d) , respectively. Of interest, confocal analysis, performed on heart samples taken at the 6 month time point, showed that NEXN was abundantly expressed in hyperglycemic mice compared with age-matched normoglycemic controls and unevenly distributed along sarcomeres, thus suggesting the presence of a potential contractile dysfunction (Supplemental Fig. 3A) . The alteration in the structure of the cardiac tissue has been further explored by hematoxylin/eosin and AzanMallory stainings of cardiac sections (34, 60) (Supplemental Fig. 3B) . The results show a myofibrillar disorganization and an increase of fibrosis detectable in the left ventricle of mice made hyperglycemic after 6 months from STZ injection. Consistently, in these animals a significant increase in the heart/body weight ratio became detectable at the same time point (Supplemental Fig. 3C ) paralleled by a decrease of survival at 5 and 6 months after STZ injection (Supplemental Fig. 4C ). In agreement with our observations in H9C2 [see Fig. 3(a) ], in vivo ChIP assays, performed by using normal or STZ-treated CD1 mice taken at the 6 month time point, showed a significant recruitment of CREM on both NEXN and ADRA2 promoters, paralleled by reduction of HDAC1 and increase in panH3Ac level [ Fig. 4(e) ].
Sildenafil rescues HG consequences in hyperglycemic mice
Sildenafil is an important modulator of PDE5 able to increase the intracellular content of cGMP, the NO-dependent second messenger. We tested the effect of sildenafil on STZ-injected mice. Specifically, sildenafil was administered daily for 12 weeks, after the first 3 months since STZ injection (see Materials and Methods). No difference in blood glucose level or survival was observed in STZ plus sildenafil-treated compared with STZ-injected mice (Supplemental Fig. 4B and 4C) . The results show that sildenafil determined a significant reduction of ANP expression [ Fig. 5(a) ], suggesting a beneficial effect of sildenafil on the heart in the presence of prolonged hyperglycemia. Consistently, sildenafil determined a downregulation of both CREM and NEXN at mRNA and protein levels [ Fig. 5(a) and 5(b) ]. These data indicate that sildenafil ameliorates cardiac gene expression in mice exposed to prolonged hyperglycemia. To explore whether sildenafil affected CREM binding to DNA, ChIP experiments were performed in H9C2 to evaluate CREM recruitment to NEXN promoter. Supplemental Fig. 3D shows that in the presence of sildenafil, CREM occupancy to this regulatory region was significantly reduced whereas HDAC1 binding recovered and H3K9Ac signal decreased compared with HG. Collectively, these data suggest that sildenafil counteracts changes in gene expression induced by HG by fine-tuning chromatin structure and the local recruitment of important transcription factors to specific gene loci.
Discussion
Hyperglycemia is a condition that precedes or accompanies more severe syndromes, including metabolic syndrome, insulin resistance, or diabetes. An important phenomenon associated with prolonged uncontrolled hyperglycemia is the onset of the so-called "hyperglycemic memory" (61) . Although it is agreed that the lag time between the onset of hyperglycemia and the therapeutic control of blood glucose level is an important contributor to epigenetic changes that may persist even after the glycemic control is achieved (62) , the intimate epigenetic nature of this phenomenon is unclear (63) . In detail, one of the leading hypotheses in the field is that epigenetic landscape modifications associated with glycemic memory are consequence of early established metabolic alteration (42, 61, (64) (65) (66) (67) . In the worst case, this alteration has been reported to be associated with clinical complications frequent in diabetes (68) (69) (70) . However, the mechanisms by which hyperglycemia may lead to hyperglycemic memory are still poorly understood, although epigenetic mechanisms are strongly thought to be involved (71) . Prior work from our group indicated that specific epigenetic marks and altered gene expression may occur in cardiac fibroblasts isolated from donors with clinical history of diabetes (42) . In the present study we investigated how the exposure to HG could alter gene expression in cultured cardiomyocytes or in the heart of mice made hyperglycemic by STZ injection and followed up for 6 months. We found that in both in vitro and in vivo hyperglycemia models, H3 lysine modifications such as the K27 trimethylation and K9 acetylation were strongly affected. These epigenetic changes were detected in the presence of HG and possibly underlined some global chromatin structural changes compatible with a less accessible DNA structure. The functional consequences of these modifications are still unclear, and a number of positive and negative changes in gene expression have been often associated to HG in endothelial cells or cardiomyocytes (72, 73) . In our study, the increased density in H3K27me3 coupled to the reduction in H3K9Ac is associated with condensed chromatin and repressed transcription. At the specific gene level, however, other modifications not specifically considered in this study, such as DNA cytosine methylation, may occur, leading to local gene transcriptional activation or further repression. Intriguingly, our experiments indicated that HAT and HDAC activities where differentially regulated by HG. Whereas HAT activity decreased significantly, total HDAC function was found to be unchanged or increased when that of HDAC2, inhibited by NO signaling, was explored (10) . This difference may reflect an altered metabolic environment determined by HG. The activity of enzymes involved in the control of the histone code modifications may, in fact, be associated with changes in the production of specific metabolites that control function of epigenetic enzymes (74, 75) . NO is one of the most important metabolites in the cardiovascular system, and alteration in NO production has been associated with aging, vascular dysfunction, metabolic syndrome, and diabetes (76, 77) . NO is also an epigenetic regulator capable of changing the epigenetic landscape of cells according to its fluctuations (78, 79) . In this regard, we found in the present study that an exogenous source of NO prevented alterations in gene expression associated to HG in cultured cardiomyocytes. Interestingly, one of the mechanisms associated with the epigenetic properties of NO relies on the nitrosylation of HDAC2. Specifically, NO nitrosylates HDAC2 and inhibits its DNA binding and function (9, 10) . HDACs have been reported to regulate inflammatory genes, and HDAC inhibitors are known for their antiproliferative and anti-inflammatory properties (80) . Hyperglycemia is often associated with inflammatory conditions that are preparatory to metabolic syndrome and diabetes; however, the mechanism leading to the upregulation of inflammatory pathways (81) is presently unknown, but it may rely on the activation of specific transcription programs.
The transcription factor CREM is an interesting component of a family of related factors transcriptionally associated with the control of cAMP signaling and cardiovascular gene expression. Its inactivation has been reported to determine reduction in cardiac contractility as well as to be protective in the presence of b-adrenergic stimulation leading to fibrosis and cardiomyopathy (22, (82) (83) (84) . Of note, members of the CREM family have been implicated in the pathophysiological response to fatty acids and hyperglycemia (33, 85) . In this study, we observed that CREM expression increased significantly in HG or in the heart of mice injected with STZ at 6 months after injection. In these experiments, CREM expression was coincident with the increase of other functional and structural cardiac gene such as NEXN or ADRA2. Indeed, we found that CREM regulated these genes directly interacting with their promoter regions, thus suggesting a role for CREM as a stress sensor to hyperglycemia in cardiac cells and in the heart.
Sildenafil is a well-characterized inhibitor of phosphodiesterase type 5 and it is used in various clinical settings to increase the intracellular levels of cGMP, the NO-dependent product of guanylate cyclase synthase. Notably cGMP mediates some of the physiological epigenetic effects of NO (54, 55) , and it can modulate b-adrenergic signaling (84) . In light of this evidence, we reasoned that sildenafil could be beneficial in preventing some of the changes in gene expression associated with hyperglycemia. Both in vitro and in vivo, sildenafil reverted the effect of HG or that of prolonged hyperglycemia determined by STZ injection, and a similar effect was obtained in vitro in the presence of the spontaneous NO donor DETA/NO. In conclusion, this study provides evidence that a dysregulation in the NO/cGMP pathway that follows the increase of glucose associated with hyperglycemia, metabolic syndrome, or diabetes may be at the basis of the epigenetic and gene expression alterations described herein, a process potentially leading to diabetic cardiomyopathy. The identification of the transcription factor CREM as a potential effector of the altered gene expression profile determined by HG shed new light on a possible target for therapeutic interventions aimed at preventing or ameliorating the onset of diabetes complications.
